Pharmacological Management Options for the Treatment of Obesity
-
Register
- User - $40
This presentation will review the pharmacological options for the treatment of obesity, review lifestyle intervention prescribing, discuss weight loss targets for the reduction of cardiovascular disease and diabetes progression.
Credits: 1.50 Contact Hours; 1.10 are Pharmacology
Expiration Date: December 31st, 2025
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Ramifications of obesity as a epidemic
Identify barriers and stigma associated with obesity as a chronic disease
-Increase understanding of the pharmacological options for weight intervention
-Understand CGM and a lifestyle interventional tool
Eden Miller, DO, Diplomate ABOM
Founder, CEO, Family Practitioner
Diabetes Nation, Diabetes and Obesity Care LLC
Dr. Eden Miller, an Osteopathic board-certified Family Practitioner, received her medical degree from Kirksville College of Osteopathic Medicine in 1997. Returning to the Northwest, she completed her residency in Family Practice at East Moreland Hospital in Portland, Oregon. Recently completing her certification in Obesity management, she is the founder of Diabetes Nation a nonprofit organization, and CEO of Diabetes and Obesity Care LLC where she practices with her husband Dr. Kevin Miller in Bend.
Dr. Miller has cultivated a special interest in diabetes, after contracting type-1 diabetes while in medical school. Out of that personal experience, her practice has extended into a subspecialty in diabetes care. An impassioned speaker, Dr. Miller has given over 1250 lectures in the field of Diabetes to health care providers and patients alike, on subjects such as Diabetes Management, CGM Technology, Insulin Pump Therapy, Obesity and Metabolism intervention, Clinical Research, and Healthcare Policy. Her adage for care is that she “only succeeds as a provider if she turns patients into experts on their own disease”.
Dr. Miller believes that a “physiologic patient individualized approach to diabetes intervention is crucial to success. She feels if our nation is to triumph over the ravages of diabetes, a collaborative effort; unhindered by fear of personal scrutiny, and barriers for effective treatment need to be removed”.
For her, Diabetes and Obesity Care provides the foundational model to impact the people that represent this disease and begin the process of restoring hope back to their lives.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Eden Miller, DO, Diplomate ABOM has disclosed:
Advisory Board: Abbott, Lilly USA, Boehringer Ingelheim, Sanofi Aventis, Novo Nordisk, Merck, Bayer, Plenity
Speaker Bureau: Abbott, Lilly USA, Boehringer Ingelheim, Novo Nordisk, Bayer
Research: Abbott
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
